SPONSORED CONTENT
The revised 340B Rebate Model is moving forward, and with implementation now scheduled for January 1, 2027, covered entities have entered a new phase of preparation. While many questions remain, one thing is clear: organizations should begin evaluating the operational, financial, and compliance impacts now.
Join PharmaForce’s pharmacy and regulatory experts for an executive briefing on what the revised pilot means, what has changed, and the practical steps covered entities should be taking in the months ahead.
During this session, we’ll discuss:
• The latest updates from HRSA and what they mean for covered entities
• Key implementation dates and milestones to keep on your radar
• Operational and compliance considerations as the rebate model takes shape
• Common questions we’re hearing from 340B leaders across the country
• Practical strategies organizations can begin evaluating today to prepare for implementation
Whether you’re responsible for pharmacy operations, compliance, finance, or 340B program oversight, this webinar will provide the insight and context you need to confidently prepare for what’s ahead.
Speakers:
